Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 83

1.

Ruminococcin C, a promising antibiotic produced by a human gut symbiont.

Chiumento S, Roblin C, Kieffer-Jaquinod S, Tachon S, Leprètre C, Basset C, Aditiyarini D, Olleik H, Nicoletti C, Bornet O, Iranzo O, Maresca M, Hardré R, Fons M, Giardina T, Devillard E, Guerlesquin F, Couté Y, Atta M, Perrier J, Lafond M, Duarte V.

Sci Adv. 2019 Sep 25;5(9):eaaw9969. doi: 10.1126/sciadv.aaw9969. eCollection 2019 Sep.

2.

Symbiotic microbes and potential pathogens in the intestine of dead southern right whale (Eubalaena australis) calves.

Marón CF, Kohl KD, Chirife A, Di Martino M, Fons MP, Navarro MA, Beingesser J, McAloose D, Uzal FA, Dearing MD, Rowntree VJ, Uhart M.

Anaerobe. 2019 Jun;57:107-114. doi: 10.1016/j.anaerobe.2019.04.003. Epub 2019 Apr 6.

PMID:
30959166
3.

Draft Genome Sequence of Shewanella algidipiscicola H1, a Highly Chromate-Resistant Strain Isolated from Mediterranean Marine Sediments.

Baaziz H, Lemaire ON, Jourlin-Castelli C, Iobbi-Nivol C, Méjean V, Alatou R, Fons M.

Microbiol Resour Announc. 2018 Aug 30;7(8). pii: e00905-18. doi: 10.1128/MRA.00905-18. eCollection 2018 Aug.

4.

Heterologous Biosynthesis, Modifications and Structural Characterization of Ruminococcin-A, a Lanthipeptide From the Gut Bacterium Ruminococcus gnavus E1, in Escherichia coli.

Ongey EL, Giessmann RT, Fons M, Rappsilber J, Adrian L, Neubauer P.

Front Microbiol. 2018 Jul 26;9:1688. doi: 10.3389/fmicb.2018.01688. eCollection 2018.

5.

ChrASO, the chromate efflux pump of Shewanella oneidensis, improves chromate survival and reduction.

Baaziz H, Gambari C, Boyeldieu A, Ali Chaouche A, Alatou R, Méjean V, Jourlin-Castelli C, Fons M.

PLoS One. 2017 Nov 22;12(11):e0188516. doi: 10.1371/journal.pone.0188516. eCollection 2017.

6.

The General Stress Response σS Is Regulated by a Partner Switch in the Gram-negative Bacterium Shewanella oneidensis.

Bouillet S, Genest O, Jourlin-Castelli C, Fons M, Méjean V, Iobbi-Nivol C.

J Biol Chem. 2016 Dec 9;291(50):26151-26163. Epub 2016 Nov 3.

7.

Efficient respiration on TMAO requires TorD and TorE auxiliary proteins in Shewanella oneidensis.

Lemaire ON, Honoré FA, Jourlin-Castelli C, Méjean V, Fons M, Iobbi-Nivol C.

Res Microbiol. 2016 Oct;167(8):630-637. doi: 10.1016/j.resmic.2016.05.004. Epub 2016 Jun 8.

PMID:
27288570
8.

Ruminococcus gnavus E1 modulates mucin expression and intestinal glycosylation.

Graziani F, Pujol A, Nicoletti C, Dou S, Maresca M, Giardina T, Fons M, Perrier J.

J Appl Microbiol. 2016 May;120(5):1403-17. doi: 10.1111/jam.13095. Epub 2016 Apr 4.

9.

Effects of a sulfonylurea herbicide on the soil bacterial community.

Arabet D, Tempel S, Fons M, Denis Y, Jourlin-Castelli C, Armitano J, Redelberger D, Iobbi-Nivol C, Boulahrouf A, Méjean V.

Environ Sci Pollut Res Int. 2014 Apr;21(8):5619-27. doi: 10.1007/s11356-014-2512-9. Epub 2014 Jan 14.

PMID:
24420563
10.

Utilisation of mucin glycans by the human gut symbiont Ruminococcus gnavus is strain-dependent.

Crost EH, Tailford LE, Le Gall G, Fons M, Henrissat B, Juge N.

PLoS One. 2013 Oct 25;8(10):e76341. doi: 10.1371/journal.pone.0076341. eCollection 2013.

11.

Therapeutic DNA vaccination using in vivo electroporation followed by standard of care therapy in patients with genotype 1 chronic hepatitis C.

Weiland O, Ahlén G, Diepolder H, Jung MC, Levander S, Fons M, Mathiesen I, Sardesai NY, Vahlne A, Frelin L, Sällberg M.

Mol Ther. 2013 Sep;21(9):1796-805. doi: 10.1038/mt.2013.119. Epub 2013 Jun 11.

12.

Oncocytoma of the nasal cavity: A case report.

Fons ME, Poetker D, Wakely PE Jr.

Ear Nose Throat J. 2013 Mar;92(3):E17-9. Review.

PMID:
23532656
13.

Functional analysis of family GH36 α-galactosidases from Ruminococcus gnavus E1: insights into the metabolism of a plant oligosaccharide by a human gut symbiont.

Cervera-Tison M, Tailford LE, Fuell C, Bruel L, Sulzenbacher G, Henrissat B, Berrin JG, Fons M, Giardina T, Juge N.

Appl Environ Microbiol. 2012 Nov;78(21):7720-32. doi: 10.1128/AEM.01350-12. Epub 2012 Aug 24.

14.

Characterization and purification of a bacteriocin from Lactobacillus paracasei subsp. paracasei BMK2005, an intestinal isolate active against multidrug-resistant pathogens.

Bendjeddou K, Fons M, Strocker P, Sadoun D.

World J Microbiol Biotechnol. 2012 Apr;28(4):1543-52. doi: 10.1007/s11274-011-0958-1. Epub 2011 Dec 3.

PMID:
22805936
15.

Extracolonic gastrointestinal tract morphologic findings in a case of pseudomembranous collagenous colitis.

Fons ME, Stein DJ, Patel A, Ferrer MS, Ammon H, Mackinnon AC, Komorowski RA, Yan BC.

Ann Diagn Pathol. 2013 Jun;17(3):291-4. doi: 10.1016/j.anndiagpath.2012.04.003. Epub 2012 Jun 1.

PMID:
22658854
16.

Characterization and distribution of the gene cluster encoding RumC, an anti-Clostridium perfringens bacteriocin produced in the gut.

Pujol A, Crost EH, Simon G, Barbe V, Vallenet D, Gomez A, Fons M.

FEMS Microbiol Ecol. 2011 Nov;78(2):405-15. doi: 10.1111/j.1574-6941.2011.01176.x. Epub 2011 Sep 6.

17.

Aga1, the first alpha-Galactosidase from the human bacteria Ruminococcus gnavus E1, efficiently transcribed in gut conditions.

Aguilera M, Rakotoarivonina H, Brutus A, Giardina T, Simon G, Fons M.

Res Microbiol. 2012 Jan;163(1):14-21. doi: 10.1016/j.resmic.2011.10.005. Epub 2011 Oct 14.

PMID:
22036918
18.

α-Galactosidase/sucrose kinase (AgaSK), a novel bifunctional enzyme from the human microbiome coupling galactosidase and kinase activities.

Bruel L, Sulzenbacher G, Cervera Tison M, Pujol A, Nicoletti C, Perrier J, Galinier A, Ropartz D, Fons M, Pompeo F, Giardina T.

J Biol Chem. 2011 Nov 25;286(47):40814-23. doi: 10.1074/jbc.M111.286039. Epub 2011 Sep 19.

19.

Ruminococcin C, a new anti-Clostridium perfringens bacteriocin produced in the gut by the commensal bacterium Ruminococcus gnavus E1.

Crost EH, Ajandouz EH, Villard C, Geraert PA, Puigserver A, Fons M.

Biochimie. 2011 Sep;93(9):1487-94. doi: 10.1016/j.biochi.2011.05.001. Epub 2011 May 11.

PMID:
21586310
20.

Viral Pathogenesis.

Baron S, Fons M, Albrecht T.

In: Baron S, editor. Medical Microbiology. 4th edition. Galveston (TX): University of Texas Medical Branch at Galveston; 1996. Chapter 45.

21.

Effects on Cells.

Albrecht T, Fons M, Boldogh I, Rabson AS.

In: Baron S, editor. Medical Microbiology. 4th edition. Galveston (TX): University of Texas Medical Branch at Galveston; 1996. Chapter 44.

22.

Auditory hallucinations in anorexia nervosa.

Rojo-Moreno L, Plumed JJ, Fons MB, Gonzalez-Piqueras JC, Rojo-Bofill L, Livianos L.

Eur Eat Disord Rev. 2011 Nov-Dec;19(6):494-500. doi: 10.1002/erv.1084. Epub 2011 Mar 10. Review.

PMID:
21394834
23.

Piezoelectric permeabilization of mammalian dermal tissue for in vivo DNA delivery leads to enhanced protein expression and increased immunogenicity.

Broderick KE, Kardos T, McCoy JR, Fons MP, Kemmerrer S, Sardesai NY.

Hum Vaccin. 2011 Jan-Feb;7 Suppl:22-8. Epub 2011 Jan 1.

PMID:
21263230
24.

Production of an antibacterial substance in the digestive tract involved in colonization-resistance against Clostridium perfringens.

Crost EH, Pujol A, Ladiré M, Dabard J, Raibaud P, Carlier JP, Fons M.

Anaerobe. 2010 Dec;16(6):597-603. doi: 10.1016/j.anaerobe.2010.06.009. Epub 2010 Jul 21.

PMID:
20603221
25.

Improving on the ability of endogenous hepatitis B core antigen to prime cytotoxic T lymphocytes.

Nyström J, Chen A, Frelin L, Ahlén G, Koh S, Brass A, Peterson DL, Fons M, Milich DR, Hultgren C, Sällberg M.

J Infect Dis. 2010 Jun 15;201(12):1867-79. doi: 10.1086/652808.

PMID:
20446851
26.

Cutaneous leiomyosarcoma originating in a symplastic pilar leiomyoma: a rare occurrence and potential diagnostic pitfall.

Fons ME, Bachhuber T, Plaza JA.

J Cutan Pathol. 2011 Jan;38(1):49-53. doi: 10.1111/j.1600-0560.2009.01420.x.

PMID:
19780873
27.

Tolerability of two sequential electroporation treatments using MedPulser DNA delivery system (DDS) in healthy adults.

Wallace M, Evans B, Woods S, Mogg R, Zhang L, Finnefrock AC, Rabussay D, Fons M, Mallee J, Mehrotra D, Schödel F, Musey L.

Mol Ther. 2009 May;17(5):922-8. doi: 10.1038/mt.2009.27. Epub 2009 Mar 10.

28.

In vivo electroporation enhances the immunogenicity of hepatitis C virus nonstructural 3/4A DNA by increased local DNA uptake, protein expression, inflammation, and infiltration of CD3+ T cells.

Ahlén G, Söderholm J, Tjelle T, Kjeken R, Frelin L, Höglund U, Blomberg P, Fons M, Mathiesen I, Sällberg M.

J Immunol. 2007 Oct 1;179(7):4741-53.

29.

Escherichia coli mutators: selection criteria and migration effect.

Le Chat L, Fons M, Taddei F.

Microbiology. 2006 Jan;152(Pt 1):67-73. doi: 10.1099/mic.0.28418-0.

PMID:
16385116
30.

Nickel potentiates the genotoxic effect of benzo[a]pyrene in Chinese hamster lung V79 cells.

Deng CZ, Fons MP, Rosenblatt J, El-Zein RA, Abdel-Rahman SZ, Albrecht T.

Environ Mol Mutagen. 2006 Apr;47(3):150-61.

PMID:
16329104
31.

Differential mutagen sensitivity of peripheral blood lymphocytes from smokers and nonsmokers: effect of human cytomegalovirus infection.

Albrecht T, Deng CZ, Abdel-Rahman SZ, Fons M, Cinciripini P, El-Zein RA.

Environ Mol Mutagen. 2004;43(3):169-78.

PMID:
15065204
32.

[Impact of mutation rate on the adaptation of gut bacteria].

Giraud A, Fons M, Taddei F.

J Soc Biol. 2003;197(4):389-96. Review. French.

PMID:
15005521
33.
34.

Distribution of genes encoding the trypsin-dependent lantibiotic ruminococcin A among bacteria isolated from human fecal microbiota.

Marcille F, Gomez A, Joubert P, Ladiré M, Veau G, Clara A, Gavini F, Willems A, Fons M.

Appl Environ Microbiol. 2002 Jul;68(7):3424-31.

35.

Mutator bacteria as a risk factor in treatment of infectious diseases.

Giraud A, Matic I, Radman M, Fons M, Taddei F.

Antimicrob Agents Chemother. 2002 Mar;46(3):863-5.

37.

Ruminococcin A, a new lantibiotic produced by a Ruminococcus gnavus strain isolated from human feces.

Dabard J, Bridonneau C, Phillipe C, Anglade P, Molle D, Nardi M, Ladiré M, Girardin H, Marcille F, Gomez A, Fons M.

Appl Environ Microbiol. 2001 Sep;67(9):4111-8.

38.

Costs and benefits of high mutation rates: adaptive evolution of bacteria in the mouse gut.

Giraud A, Matic I, Tenaillon O, Clara A, Radman M, Fons M, Taddei F.

Science. 2001 Mar 30;291(5513):2606-8.

39.
40.

Cell-division-cycle defects associated with fission yeast pre-mRNA splicing mutants.

Potashkin J, Kim D, Fons M, Humphrey T, Frendewey D.

Curr Genet. 1998 Sep;34(3):153-63.

PMID:
9745017
41.

Cell wall anchoring of the Streptococcus pyogenes M6 protein in various lactic acid bacteria.

Piard JC, Hautefort I, Fischetti VA, Ehrlich SD, Fons M, Gruss A.

J Bacteriol. 1997 May;179(9):3068-72.

42.

Increased frequency of specific locus mutation following human cytomegalovirus infection.

Albrecht T, Fons MP, Deng CZ, Boldogh I.

Virology. 1997 Mar 31;230(1):48-61.

43.

Isolation and characterization of a plasmid from Lactobacillus fermentum conferring erythromycin resistance.

Fons M, Hégé T, Ladiré M, Raibaud P, Ducluzeau R, Maguin E.

Plasmid. 1997;37(3):199-203.

PMID:
9200223
44.
45.
46.

Multiple herpesviruses in saliva of HIV-infected individuals.

Fons MP, Flaitz CM, Moore B, Prabhakar BS, Nichols CM, Albrecht T.

J Am Dent Assoc. 1994 Jun;125(6):713-9.

PMID:
8014336
47.

Human cytomegalovirus infection increases the number of ouabain-binding sites in human fibroblasts.

Altamirano AA, Fons MP, Russell JM, Cragoe EJ Jr, Albrecht T.

Virology. 1994 Feb 15;199(1):151-9.

PMID:
8116238
48.

Increased levels of sequence-specific DNA-binding proteins in human cytomegalovirus-infected cells.

Boldogh I, Fons MP, Albrecht T.

Biochem Biophys Res Commun. 1993 Dec 30;197(3):1505-10.

PMID:
8280168
49.

Modulation of the frequency of human cytomegalovirus-induced chromosome aberrations by camptothecin.

Deng CZ, AbuBakar S, Fons MP, Boldogh I, Albrecht T.

Virology. 1992 Jul;189(1):397-401.

PMID:
1318615
50.

Receptor-initiated activation of cells and their oncogenes by herpes-family viruses.

Albrecht T, Boldogh I, Fons MP.

J Invest Dermatol. 1992 Jun;98(6 Suppl):29S-35S. Review.

Supplemental Content

Support Center